Lachlan Brown

Stock Analyst at William Blair

(2.65)
# 2,237
Out of 5,106 analysts
11
Total ratings
55.56%
Success rate
19.95%
Average return

Stocks Rated by Lachlan Brown

Viridian Therapeutics
Dec 3, 2025
Initiates: Outperform
Price Target: n/a
Current: $32.31
Upside: -
Manhattan Associates
Jun 10, 2025
Downgrades: Neutral
Price Target: $270$200
Current: $173.73
Upside: +15.12%
Harrow
Jun 10, 2025
Initiates: Outperform
Price Target: n/a
Current: $47.06
Upside: -
Kalaris Therapeutics
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $8.87
Upside: -
Ocular Therapeutix
Apr 8, 2025
Initiates: Outperform
Price Target: n/a
Current: $14.56
Upside: -
Synopsys
Jan 13, 2025
Initiates: Buy
Price Target: $600
Current: $452.95
Upside: +32.46%
Cadence Design Systems
Jan 13, 2025
Initiates: Buy
Price Target: $350
Current: $323.22
Upside: +8.29%
Apellis Pharmaceuticals
Oct 16, 2024
Initiates: Outperform
Price Target: n/a
Current: $25.23
Upside: -
The Descartes Systems Group
May 14, 2024
Initiates: Neutral
Price Target: $90
Current: $90.71
Upside: -0.78%
SPS Commerce
May 14, 2024
Initiates: Buy
Price Target: $220
Current: $86.23
Upside: +155.13%